乳房自体脂肪移植受区预处理能否提高脂肪存留率:前瞻性多中心随机对照试验
该前瞻性多中心2×2析因随机对照试验纳入60例女性患者,比较受区预扩张、预热、两者联合与对照对乳房自体脂肪移植6个月脂肪存留率的影响。结果显示各预处理方式与对照在脂肪存留率上无统计学显著差异,各组瘢痕质量与疼痛均有改善但组间无差异,所有预处理方法耐受良好且无严重不良事件。
要点
- 受区预扩张、预热或联合预处理未显著提高6个月脂肪存留率。
- 所有组(含对照)瘢痕质量与疼痛均有改善,组间无差异。
- 预处理方法安全性良好,值得在更大样本试验中进一步研究。
核心结论
- 受区预扩张、预热或两者联合均未在6个月时显著改善乳房自体脂肪移植的脂肪存留率、疼痛或瘢痕。
- 鉴于安全性、可行性和生物学合理性,这些技术值得在更大样本、把握度充分的试验中进一步研究。
研究设计与样本
- 前瞻性、多中心、随机对照试验,采用2×2析因设计,共60例女性患者。
- 分为四组:预扩张组(Kiwi® VAC-6000M联合PalmPump™)、预热组(HILOTHERM® Calido系统)、联合组和未预处理对照组。
- 主要结局为术后6个月乳房脂肪移植体积存留百分比(相对筛查时基线)。
- 次要结局包括瘢痕质量(Patient and Observer Scar Assessment Scale)、疼痛(Numeric Rating Scale)和并发症(Clavien-Dindo分类)。
- 证据等级为Level 1(随机临床试验)。
主要发现
- 治疗组与对照组6个月脂肪存留率无统计学显著差异。
- 所有组(包括对照组)瘢痕质量改善、疼痛减轻,但组间无差异。
- 所有预处理方法耐受良好,未报告严重不良事件。
临床怎么用
- 目前证据不支持将受区预扩张或预热作为提高乳房脂肪移植存留率的常规措施。
- 预处理方法安全性良好,可在充分知情和研究框架下个体化考虑。
局限性
- 样本量为60例,可能不足以检测组间差异。
- 随访仅至术后6个月,缺乏更长期结局。
- 未识别最可能获益的患者亚组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous fat grafting (AFG) is a popular method for soft tissue augmentation and reconstruction due to its regenerative potential and minimally invasive nature. However, variability in fat graft retention remains a major limitation. While research has focused on optimizing fat harvesting and processing techniques, the role of recipient site preparation has been understudied. This trial evaluated whether preconditioning the recipient site-via pre-expansion, pre-heating, or both-could enhance fat graft retention around the breast six months post-operatively. PATIENTS AND METHODS: In a prospective, multi-center, randomized controlled trial (RCT) with a 2×2 factorial design, 60 female patients were assigned to one of four groups: (1) pre-expansion using the Kiwi® VAC-6000M with PalmPump™, (2) pre-heating using the HILOTHERM® Calido system, (3) a combination of both interventions, or (4) a control group without preconditioning. The primary outcome was the percentage of fat graft volume retained at the breast at six months relative to baseline at screening. Secondary outcomes included scar quality (Patient and Observer Scar Assessment Scale), pain levels (Numeric Rating Scale), and complications (Clavien-Dindo classification). RESULTS: No statistically significant difference in fat retention was observed between the treatment and control groups at six months. All groups (including control) showed improvement in scar quality and reduced pain, though the improvement was not different between the arms. All preconditioning methods were well tolerated, and no serious adverse events were reported. CONCLUSIONS: This is the first RCT to evaluate recipient site preconditioning in AFG around the breast. The interventions did not yield statistically significant improvements in fat graft survival, pain, or scarring. Given their safety, feasibility, and the biological rationale supporting their use, these techniques warrant further investigation in larger, adequately powered trials. Future studies should focus on identifying patient subgroups most likely to benefit and exploring long-term outcomes beyond six months. LEVEL OF EVIDENCE: Level 1 (randomized clinical trial).
引用
- Speck NE, Ciftci Ü, Speck NM, et al. Is there an ideal recipient site preconditioning to improve autologous fat graft retention in breast surgery? A prospective multi-center randomized controlled trial. J Plast Reconstr Aesthet Surg. 2025. PMID: 41389580. doi:10.1016/j.bjps.2025.11.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。